LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

LLY

1,136.74

+4.61%↑

JNJ

227.5

+1.33%↑

ABBV

222.33

+1.68%↑

UNH

395.67

+3.16%↑

MRK

119.04

+2.72%↑

Search

Zoetis Inc

Open

SectorHealthcare

80.37 4.54

Overview

Share price change

24h

Current

Min

76.36

Max

81.52

Key metrics

By Trading Economics

Income

-2M

601M

Sales

-125M

2.3B

P/E

Sector Avg

12.715

49.888

EPS

1.42

Dividend yield

2.61

Profit margin

26.569

Employees

14,500

EBITDA

-6M

941M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+59.25% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

2.61%

2.38%

Next Earnings

4 Aug 2026

Next Dividend date

1 Sept 2026

Next Ex Dividend date

20 Jul 2026

Market Stats

By TradingEconomics

Market Cap

-15B

33B

Previous open

75.83

Previous close

80.37

News Sentiment

By Acuity

52%

48%

259 / 344 Healthcare

Zoetis Inc Chart

Past performance is not a reliable indicator of future results.

Related News

5 Aug 2025, 11:06 UTC

Earnings

Zoetis Sees 2025 Adj EPS $6.30-Adj EPS $6.40 >ZTS

5 Aug 2025, 11:06 UTC

Earnings

Zoetis Sees 2025 Rev $9.45B-$9.6B >ZTS

5 Aug 2025, 11:05 UTC

Earnings

Zoetis 2Q Adj EPS $1.76 >ZTS

Peer Comparison

Price change

Zoetis Inc Forecast

Price Target

By TipRanks

59.25% upside

12 Months Forecast

Average 123.56 USD  59.25%

High 150 USD

Low 95 USD

Based on 12 Wall Street analysts offering 12 month price targets forZoetis Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

6

Buy

6

Hold

0

Sell

Sentiment

By Acuity

259 / 344 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Zoetis Inc

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
help-icon Live chat